AYA Oncology Self-Care Movement: influencer-driven social media for oral chemo adherence
Official title: The AYA Oncology Self-Care Movement (#AYAOSM): An Influencer-Driven Social Media Intervention for Oral Chemotherapy Adherence
Funded at Lurie Children's Hospital of Chicago · NIH-11419207 · Data updated 2026-11-12
A tailored social‑media intervention led by influencers helps adolescents and young adults with acute lymphoblastic leukemia take their oral chemotherapy more consistently.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lurie Children's Hospital of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | September 19, 2025 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $549,548 |
| NIH project number | 5R37CA299904-02 |
| Project ID | NIH-11419207 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adolescents and young adults diagnosed with acute lymphoblastic leukemia who are prescribed oral chemotherapy.
✕Less likely to help
AYAs not using oral chemo or no access to social media platforms used in the intervention may not benefit.
What this research studies
Young patients with acute lymphoblastic leukemia often struggle to take oral chemotherapy on schedule. This project tests a social media approach co-designed with AYAs to support daily medication routines using platforms they already use. The study will involve delivering focused content through influencers and monitoring adherence to a 95% target, with feedback from participants to refine the method. If successful, this scalable digital strategy could reduce relapse risk and close adherence gaps in the AYA cancer population.
Why it matters
Potential benefit: If successful, patients could maintain remission more reliably through better adherence to their oral chemotherapy regimens.
How similar studies have gone: Early work suggests digital, peer-influenced support can improve health behaviors, but this approach is novel for AYA oral chemo adherence.
Where this research is happening
-
Lurie Children's Hospital of Chicago
Chicago, United States Active
Researchers
- Principal investigator: Psihogios, Alexandra — Lurie Children's Hospital of Chicago
- Study coordinator: Psihogios, Alexandra
Related research
Other NIH-funded projects on the same topics.
-
Photodynamic lipids to boost chemotherapy for metastatic ovarian cancer
A patient-friendly approach tests a light-activated method to make ovarian cancer metastases more sensitive to chemotherapy.
-
Dual targeting of heart cell receptors to prevent chemotherapy heart damage
Atrial patients receiving the chemotherapy drug doxorubicin may be protected from heart damage by targeting two heart cell receptors at once.
-
A 3D ultrasound scanner to see early chemotherapy response in breast cancer
A new 3D ultrasound imaging method will be tested to see if it can quickly show whether breast cancer is responding to chemotherapy.
-
Non-invasive, microscopic biomarkers to detect CIPN in chemotherapy patients
This grant aims to develop a non-invasive imaging method to measure nerve changes in patients undergoing chemotherapy to better understand and monitor chemotherapy-induced peripheral neuropathy (CIPN).
-
Alternative NF-kB activation after chemotherapy in ovarian cancer
This grant studies how ovarian cancer might come back after chemotherapy by looking at specific signaling pathways in cancer cells and the tumor environment.
-
Genetic clues for doxorubicin heart risk using patient-derived heart cells
A research project tests how human heart cells grown from stem cells react to a common chemotherapy to see which genetic differences may raise the risk of heart damage.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.